Recommended Pages at astrazeneca.com
AstraZeneca - NIH launches collaborative program with industry and researchers
astrazeneca.com — “AstraZeneca - NIH launches collaborative program with industry and researchers” View full resource at astrazeneca.com
Most Recently Shared on May 3, 2012 at 6:18 pm By:
AZ #collaboration w/ @MRCcomms to share compounds has received 100+ proposals across 35+ UK academic institutions http://t.co/Omw1j47E
AstraZeneca - Axerion Therapeutics and AstraZeneca to Develop and Commercialize a Biologic Approach for the Treatment of Alzheimer’s Disease
astrazeneca.com — “AstraZeneca - Axerion Therapeutics and AstraZeneca to Develop and Commercialize a Biologic Approach for the Treatment of Alzheimer’s Disease” View full resource at astrazeneca.com
Most Recently Shared on May 1, 2012 at 3:12 pm By:
Excited to #partner with Axerion Therapeutics to research #biologics for #alzheimer’s disease @medimmune http://t.co/C7yf3NKO
AstraZeneca - AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease
astrazeneca.com — “AstraZeneca - AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease” View full resource at astrazeneca.com
Most Recently Shared on April 25, 2012 at 4:45 pm By:
AZ & The Medicines Company announce global collaboration in acute ischaemic heart disease http://t.co/plWswd6t
AstraZeneca - AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash) including lead product lesinurad in Phase III development for gout
astrazeneca.com — “AstraZeneca - AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash) including lead product lesinurad in Phase III development for gout” View full resource at astrazeneca.com
Most Recently Shared on April 23, 2012 at 8:32 am By:
AZ to acquire Ardea Biosciences for $1 billion including product lesinurad in Phase III development for gout. http://t.co/vkYbixP8
AstraZeneca - AstraZeneca and DNDi to Collaborate on Drug Screening for Neglected Tropical Diseases
astrazeneca.com — “AstraZeneca - AstraZeneca and DNDi to Collaborate on Drug Screening for Neglected Tropical Diseases” View full resource at astrazeneca.com
Most Recently Shared on April 12, 2012 at 11:11 am By:
AZ & @DNDi_HQ to Collaborate on Drug Screening for 3 Neglected Tropical Diseases #NTDs http://t.co/7XMrIZB5
AstraZeneca - AstraZeneca and Amgen announce collaboration to jointly develop and commercialise clinical-stage inflammation portfolio
astrazeneca.com — “AstraZeneca, AMGEN” View full resource at astrazeneca.com
Most Recently Shared on April 2, 2012 at 8:21 pm By:
AZ & @Amgen announce #collaboration to develop & commercialise #inflammation portfolio http://t.co/39Vxeck9
AstraZeneca - Diversity and inclusion
astrazeneca.com — “Understanding the different needs and perspectives of our stakeholders is central to how we do business. Find more information at AstraZeneca.com” View full resource at astrazeneca.com
Most Recently Shared on April 2, 2012 at 1:50 pm By:
AZ launches new framework for driving culture of #diversity and inclusion http://t.co/arCwupSO
AstraZeneca - AstraZeneca Young Health Programme
astrazeneca.com — “Our Young Health Programme is designed to help young people around the world understand and deal with the health issues they face. Read more at AstraZeneca.com” View full resource at astrazeneca.com
Most Recently Shared on April 2, 2012 at 12:43 pm By:
AZ has Young Health Programmes running in 9 countries across 4 continents http://t.co/3iiBtWHu
AstraZeneca - US DISTRICT COURT FINDS SEROQUEL XR® FORMULATION PATENT VALID AND INFRINGED
astrazeneca.com — “AstraZeneca - US DISTRICT COURT FINDS SEROQUEL XR® FORMULATION PATENT VALID AND INFRINGED” View full resource at astrazeneca.com
Most Recently Shared on March 30, 2012 at 7:59 am By:
US Court finds Seroquel XR formulation patent valid & infringed http://t.co/7AYX4KVC
AstraZeneca - Responsibility
astrazeneca.com — “Find detailed information about our non-financial performance together with the latest Company positions in key issue areas. Read more at AstraZenica” View full resource at astrazeneca.com
Most Recently Shared on March 27, 2012 at 12:04 pm By:
Our 2011 Responsibility report published http://t.co/oyGo4tNU
AstraZeneca - US court denies preliminary injunction application against the FDA and dismisses AstraZeneca’s lawsuit without prejudice
astrazeneca.com — “AstraZeneca - US court denies preliminary injunction application against the FDA and dismisses AstraZeneca’s lawsuit without prejudice” View full resource at astrazeneca.com
Most Recently Shared on March 26, 2012 at 9:31 am By:
US court denies AZ’s preliminary injunction application against FDA http://t.co/nOwfIm1t
AstraZeneca - Letters from the lab: Focus on TB research
astrazeneca.com — “AstraZeneca - Letters from the lab: Focus on TB research” View full resource at astrazeneca.com
Most Recently Shared on March 22, 2012 at 9:52 am By:
Our scientists comment on their contribution towards beating a #pandemic #disease ahead of #WorldTBday http://t.co/CulYtYwA
AstraZeneca - Remaining TC-5214 Phase III efficacy studies do not meet endpoint, regulatory filing will not be pursued
astrazeneca.com — “TC-5214, Phase III studies, Targacept.” View full resource at astrazeneca.com
Most Recently Shared on March 20, 2012 at 9:59 am By:
Remaining TC-5214 Phase III efficacy studies don’t meet primary endpoint, regulatory filing not pursued http://t.co/JPYsLded
AZ CFO presented at #JPM12 on partnering opportunities & pipeline http://t.co/FECcOpu9
astrazeneca.com — “AZ CFO presented at #JPM12 on partnering opportunities & pipeline http://t.co/FECcOpu9” View full resource at astrazeneca.com
Most Recently Shared on January 13, 2012 at 5:23 pm By:
AZ CFO presented at #JPM12 on partnering opportunities & pipeline http://t.co/FECcOpu9
AstraZeneca - Dr. Briggs Morrison to join AstraZeneca R&D; Dr. Anders Ekblom to lead new Science and Technology function
astrazeneca.com — “AstraZeneca is pleased to announce the appointment of industry leading drug development expert, Dr. Briggs Morrison, to the position of Executive Vice President Global Medicines Development (GMD) reporting to the President of R&D, Dr. Martin Mackay.” View full resource at astrazeneca.com
Most Recently Shared on January 11, 2012 at 12:12 pm By:
Dr. Briggs Morrison to Join AZ R&D; Dr. Anders Ekblom to Lead New Science and Technology Function http://t.co/xI2tD2X4
